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Abstract 28 
The bifunctional protein kinase-endoribonuclease Ire1 initiates splicing of the mRNA for the 29 
transcription factor Hac1 when unfolded proteins accumulate in the endoplasmic reticulum. 30 
Activation of Saccharomyces cerevisiae Ire1 coincides with autophosphorylation of its 31 
activation loop at S840, S841, T844, and S850. Mass spectrometric analysis of Ire1 expressed 32 
in Escherichia coli identified S837 as another potential phosphorylation site in vivo. Mutation 33 
of all five potential phosphorylation sites in the activation loop decreased, but did not 34 
completely abolish, splicing of HAC1 mRNA, induction of KAR2 and PDI1 mRNAs, and 35 
expression of a β-galactosidase reporter activated by Hac1i. Phosphorylation site mutants 36 
survive low levels of ER stress better than IRE1 deletions strains. In vivo clustering and 37 
inactivation of Ire1 are not affected by phosphorylation site mutants. Mutation of D836 to 38 
alanine in the activation loop of phosphorylation site mutants nearly completely abolished 39 
HAC1 splicing, induction of KAR2, PDI1, and β-galactosidase reporters, and survival of ER 40 
stress, but had no effect on clustering of Ire1. By itself, the D836A mutation does not confer a 41 
phenotype. These data argue that D836 can partially substitute for activation loop 42 
phosphorylation in activation of the endoribonuclease domain of Ire1. 43 
Introduction 44 
Accumulation of unfolded proteins in the endoplasmic reticulum (ER) activates the 45 
bifunctional transmembrane protein kinase-endoribonuclease Ire1 (1, 2). In ER-stressed cells 46 
Ire1 oligomerises (3, 4) and concentrates in clusters at the ER membrane (5, 6) independent 47 
of its protein kinase activity (6, 7). In the yeast Saccharomyces cerevisiae, activated Ire1 48 
cleaves the mRNA for the transcription factor HAC1 to initiate removal of a 252 nt intron 49 
from HAC1 mRNA (8-11) that inhibits translation of unspliced HAC1 (HAC1u) mRNA (12). 50 
Ligation of the 5’ and 3’ exons of HAC1 mRNA by tRNA ligase produces spliced HAC1 51 
mRNA (HAC1i) (13), which is readily translated. Hac1i induces transcription of genes 52 
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encoding ER-resident molecular chaperones and protein foldases, such as BiP/KAR2 and 53 
PDI1, to alleviate the unfolded protein burden in the ER (14, 15). Many Hac1i target genes 54 
contain a short promoter element, termed the unfolded protein response element (UPRE) 55 
(16), to which Hac1i binds as a heterodimer with the transcription factor Gcn4 (17). 56 
The N-terminal lobe of protein kinases harbours an activation segment, whose start and 57 
end points are defined by the conserved amino acid sequence motifs DFG and APE in S. 58 
cerevisiae Ire1. The activation segment encompasses the Mg2+-binding loop, a short β strand, 59 
β9 [β10 in Ire1, (18)], the activation loop, and the P+1 loop (Fig. 1) (19). Phosphorylation in 60 
the activation loop activates many protein kinases (20). Phosphorylation-dependent protein 61 
kinases often display an invariant arginine (R796 in Ire1) that precedes the catalytic aspartate, 62 
D797 in Ire1 (20). Crystallographic examination of active conformations of these RD kinases 63 
has revealed that phosphoamino acids in the activation loop are in contact with a basic pocket 64 
formed by the invariant arginine, a basic amino acid located in β9 (β10 in Ire1), and often a 65 
third basic amino acid located in helix αC in the N-terminal lobe (19, 20). The invariant 66 
arginine, R796, preceding the catalytic aspartate, D797, and a lysine in β10, K833, have been 67 
conserved throughout evolution in Ire1 (Fig. 1). Mass spectrometric mapping of tryptic 68 
peptides revealed four potential phosphorylation sites in Ire1, S840, S841, T844, and S850 69 
(18). Mutational analyses illustrate the importance of phosphorylation of Ire1 in vivo. A 70 
S840A S841A double mutant displayed a large defect in induction of both KAR2 and PDI1 71 
mRNAs (3), while HAC1 splicing by a S840A S841A T844A triple mutant and survival of 72 
ER stress by a S840A S841A T844A S850A quadruple mutant were severely decreased (18, 73 
21). In addition, phosphorylation of human IRE1α increased its RNase activity towards a 74 
short, fluorescently-labelled stem loop substrate ~100-fold (22). 75 
However, HAC1 splicing in cells expressing S840A-S841A-T844A-Ire1 nevertheless 76 
reached ~20% of the level of HAC1 splicing in cells expressing WT Ire1 (21), which suggests 77 
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that the S840A S841A T844A mutant transduces a weak ER stress signal. In addition, 78 
mutation of catalytic amino acids in the protein kinase active site, for example in D828A and 79 
D797A K799A mutants, decreases, but does not abolish, processing of HAC1 mRNA by Ire1 80 
(7, 21). Finally, addition of the non-phosphorylatable ATP analogue 1-tert-butyl-3-81 
naphthalen-1-ylmethyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylemine to cells expressing protein 82 
kinase deficient mutants restored the ability to process HAC1 mRNA (23). These 83 
observations suggest that activation loop phosphorylation is dispensable for, at least partial, 84 
activation of Ire1. The purpose of this study was to elucidate mechanisms that allow Ire1 to 85 
transduce an ER stress signal in the absence of phosphorylation in its activation segment. Our 86 
work identifies an additional potential phosphorylation site in the activation segment, S837. 87 
A mutant lacking all phosphorylation sites in the activation segment, including S837, still 88 
transduces a weak ER stress signal. The ability to transduce this weak ER stress signal 89 
requires the presence of an aspartate, D836, in the activation loop. 90 
Materials and Methods 91 
Plasmid constructions. Plasmids were maintained in Escherichia coli XL10-Gold cells 92 
(Agilent Technologies, Stockport, UK, cat. no. 200314). Standard protocols were used for 93 
plasmids constructions. The single copy URA3 plasmid pJK59 (24) for expression of Sec63-94 
GFP was obtained from W. A. Prinz (National Institute of Diabetes and Digestive and Kidney 95 
Diseases, National Institutes of Health, Bethesda). 96 
YCplac33-S840A-S841A-T844A-S850A-IRE1-HA (brief YCplac33-Q-A-IRE1-HA) was 97 
generated by cloning the 2,002 bp AfeI-MscI fragment of pC3060-S840A-S841A-T844A-98 
S850A (18) into AfeI- and MscI-digested YCplac33-IRE1-HA (23). To generate YCplac33-99 
S837A-S840A-S841A-T844A-S850A-IRE1-HA (brief YCplac33-P-A-IRE1-HA) the 310 bp 100 
PstI-SacI fragment of YCplac33-Q-A-IRE1-HA was inserted into PstI- and SacI-digested 101 
pUC18 (25) and the S837A point mutation introduced by QuikChange site-directed 102 
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mutagenesis (Agilent Technologies) with primers H8293 and H8294 (Table 1). After 103 
confirmation of the mutagenised sequence by Sanger sequencing, the 3,103 bp PstI-SacI 104 
fragment was inserted into PstI- and SacI-digested YCplac33-Q-A-IRE1-HA (23). To 105 
introduce the D836A mutation into wild type (WT) Ire1 and S840A-S841A-Ire1 the 1,405 bp 106 
HindIII-SacI fragments of YCplac33-IRE1-HA and YCplac-S840A-S841-IRE1-HA (23) 107 
were cloned into HindIII- and SacI-digested pUC18, followed by introduction of the D836A 108 
mutation by Quik-Change site-directed mutagenesis with primers H8623 and H8624 in the 109 
case of WT Ire1 and primers H8625 and H8626 in the case of S840A-S841A-Ire1. After 110 
confirmation of the mutagenised sequence by Sanger sequencing, the 1,405 bp HindIII-SacI 111 
fragments of the two pUC18 plasmids were cloned into YCplac33-IRE1-HA to produce 112 
YCplac33-D836A-IRE1-HA and YCplac33-D836A-S840A-S841A-IRE1-HA, respectively. 113 
To introduce the D836A mutation into Q-A- and P-A-Ire1, the 1,578 bp BamHI-KpnI 114 
fragment of pGEX-1λT-Q-A-C’IRE1 (Šestak et al., unpublished) was cloned into BamHI- 115 
and KpnI-digested pUC18 and the 69 bp EcoRV-PstI fragment replaced with annealed and 116 
phosphorylated deoxyoligonucleotides H8627 and H8628 or annealed and phosphorylated 117 
deoxyoligonucleotides H8629 and H8630. The 1,578 bp KpnI-BamHI fragments of the 118 
resulting plasmids were cloned into BamHI- and KpnI-digested pAW42 (26). From the two 119 
resulting plasmids, pGEX-1λT-Q-A-C’IRE1 and pGEX-1λT-P-A-C’IRE1, the 310 bp PstI-120 
SacI fragments were cloned into PstI- and SacI-digested YCplac33-Q-A-IRE1-HA to 121 
generate YCplac33-D836A-Q-A-IRE1-HA and YCplac33-D836A-P-A-IRE1-HA. 122 
For tagging Ire1 with mCherry the 2,013 bp AfeI-SacI fragment of pEvA97 (5) was cloned 123 
into the corresponding AfeI- and SacI-digested YCplac33-IRE1-HA plasmids. Then the 3,356 124 
bp HindIII-NheI fragments of the resulting YCplac33-IRE1-HA plasmids were reinserted into 125 
pEvA97 because mCherry fluorescence was not detectable in unstressed cells when the 126 
mCherry-Ire1 fusion protein was expressed from YCplac33 in initial experiments. pGEX-127 
 7 
 
 
 
1λT-L745A-C’IRE1 was constructed by amplifying a 1,277 bp PCR product with primers 128 
8619G and H4075A04 from YCplac33-L745A-IRE1 (23), and cloning the BamHI- and PmlI-129 
digested PCR product into BamHI- and PmlI-digested pAW42. 130 
For galactose-inducible expression of HA- and protein A-tagged Dcr2 and Ptc2, the 2,777 131 
bp and 2,435 BssHII fragments of BG1805-DCR2 and BG1805-PTC2 (27) were ligated to the 132 
6,692 bp BssHII fragment of pRSII422 (28) or the 6,676 bp BssHII fragment of pRS425 (29). 133 
H338A-Dcr2 (30) and E37A-D38A-Ptc2 (31) were generated by QuikChange site-directed 134 
mutagenesis with primer pairs DCR2-H338A-F and DCR2-H338A-R and PTC2-E37A-135 
D38A-F and PTC2-E37A-D38A-R (Table 1) on BG1805-DCR2 and BG1805-PTC2, 136 
respectively. After confirmation of the mutagenised sequences by Sanger sequencing, the 137 
1,070 bp ClaI-EagI fragment of BG1805-H338A-DCR2 was cloned into ClaI- and EagI-138 
digested pRSII422-DCR2 and the 1,153 bp SacI-XhoI-fragment of BG1805-E37A-D38A-139 
PTC2 was cloned into SacI- and XhoI-digested pRSII422-PTC2 and from there the 2,777 bp 140 
BssHII fragments of pRSII422-DCR2 and pRSII422-H338A-DCR2 and the 2,435 bp BssHII-141 
fragments of pRSII422PTC2 and pRSII422-E37A-D38A-PTC2 were cloned into BssHII-142 
digested pRS425. 143 
Yeast methods. Yeast strains (Table 2) were transformed by the LiOAc method (32). Ire1 144 
was deleted in W303-1A (33) as described previously (34). DCR2 and PTC2 were deleted by 145 
PCR-based gene disruption (35) with primer pairs H9327 and H9328 and H9329 and H9330 146 
(Table 1) and pFA6a-kanMX2 (35) or pFA6a-hphNT1 (36) as template. The GAL1 promoter 147 
and a N-terminal T7 epitope tag were introduced by transforming PWY 260 with PCR 148 
constructs amplified with primer pairs H9328 and H9331 and H9330 and H9332 from 149 
plasmid pFA6a-kanMX6-PGAL1-T7. pFA6a-kanMX6-PGAL1-T7 was constructed by inserting 150 
annealed and kinased oligonucleotides U5803H01 and U5803H02 into PacI- and BamHI-151 
digested pFA6a-kanMX6-PGAL1 (37). The T7 sequence in pFA6a-kanMX6-PGAL1-T7 was 152 
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confirmed by Sanger sequencing. In frame fusion of the T7 epitope tag to the DCR2 and 153 
PTC2 open reading frames was confirmed by Sanger sequencing. 154 
To induce ER stress, cells were grown to mid-exponential growth phase on synthetic 155 
dextrose (SD) medium lacking uracil or leucine (38). 1,4-DL-Dithiothreitol (DTT) was added 156 
to a final concentration of 2 mM from a 1 M stock solution made in water. To wash out DTT, 157 
cells treated with 2 mM DTT for 2 h were washed once with SD medium lacking uracil and 158 
then resuspended in the same culture volume of fresh SD medium lacking uracil. For 159 
fluorescence microscopy the concentrations of adenine and L-tryptophan were raised to 100 160 
mg/l. Survival of ER stress was scored by spotting 2 µl of serial ten-fold dilutions of fresh 161 
overnight cultures onto freshly prepared synthetic media agar plates lacking uracil and 162 
containing 2% (w/v) glucose as carbon source. Expression of DCR2 and PTC2 from the 163 
GAL1 promoter was induced by growing the cells from single colonies in a small volume of 164 
synthetic medium with 1% (w/v) raffinose and 2% (w/v) galactose as carbon source lacking 165 
uracil, both uracil and adenine, or both uracil and leucine. Cells were then spotted onto 166 
synthetic media plates containing 1% (w/v) raffinose and 2% (w/v) galactose for ER stress 167 
survival assays. All overnight cultures were adjusted to optical densities at 600 nm of 3.0 168 
before preparing serial ten-fold dilutions. To semiquantitatively evaluate growth assays, 169 
threshold dilutions, DT, were defined as the maximum dilutions at which growth could be 170 
observed and were determined with an accuracy limit of ~0.5. The difference between the 171 
two negative decadic logarithms of the threshold dilutions for tunicamycin exposed cells and 172 
untreated cells, ∆logDT, is defined as ∆logDT = -logDT,Tm - (-logDT,u), where DT,Tm is the 173 
threshold dilution of tunicamycin-exposed cells and DT,u the threshold dilution of untreated 174 
cells. Only differences in ∆logDT ≥ 0.5 were considered to be significant. 175 
Northern analysis. Northern blotting was performed as described previously (34), except 176 
that cells were lysed by bead-beating with 0.5 mm diameter glass beads (Stratech Scientific, 177 
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Newmarket, UK, cat. no. 11079105z) in a Precellys 24 instrument (Bertin Technologies, 178 
Montigny-le-Bretonneux, France) at 4°C with two cycles of 30 s at 6,500 rpm separated by a 179 
30 s break. The probes for HAC1 (34), KAR2 (39), PDI1 (39), and the loading control pC4/2 180 
(40) were described previously. All mRNAs were quantified by phosphorimaging on a 181 
Typhoon 9400 system (GE Healthcare, Little Chalfont, UK). Volumetric measurements were 182 
normalised to the loading control pC4/2. The percentage of HAC1i (% HAC1i) is defined as 183 
% HAC1i = 
HAC1i
HAC1u + HAC1i + 1st exon & intron + 1st exon 
The percentage of HAC1 cleavage (% cleavage) is defined as 184 
% Cleavage = 
HAC1i+0.5∙(1st exon & intron + 1st exon)
HAC1u + HAC1i + 1st exon & intron + 1st exon
 
β-Galactosidase reporter assays were performed as described before (39). Cells were grown 185 
to mid-exponential phase, a zero hour sample collected, and the remainder of the culture 186 
exposed to 2 mM DTT and further samples collected after 1 h and 2 h. After washing cells 187 
with ice-cold water, protein extracts were produced in 1 x reporter lysis buffer (Promega, 188 
Southampton, UK, cat. no. E3971) by bead-beating with 0.5 mm diameter glass beads in a 189 
Precellys 24 instrument at 4°C with 3 cycles of 10 s at 6,500 rpm. Between each cycle 190 
samples were cooled for 5 min on ice. The lysates were centrifuged at 12,000 g and 4°C for 191 
10 min and supernatants were transferred into fresh microcentrifuge tubes to obtain protein 192 
extracts. β-Galactosidase activity was standardised to total protein determined with the DC 193 
protein assay from Bio-Rad Laboratories (Hemel Hempstead, UK, cat. no. 500-0116). 194 
Protein extraction and Western blotting. Mid-exponential growth phase cells were washed 195 
once with 5 ml of ice-cold water , once with 1 ml ice-cold water and then resuspended in 200 196 
µl 8 M urea, 2.5 % (w/v) SDS, 50 mM Tris·HCl, pH 7.5 (at 4°C), 6 mM EDTA, 5 mM 197 
β-mercaptoethanol, 2 mM phenylmethanesulphonyl fluoride (PMSF), and 6 mM 4-(2-198 
aminoethyl)-benzenesulphonyl fluoride (AEBSF). The cells were lysed by bead-beating as 199 
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described for the β-galactosidase reporter assays. Protein concentrations were quantified with 200 
bicinchoninic acid (41) after alkylation of β-mercaptoethanol with 0.1 M iodoacetamide in 201 
0.1 M Tris·HCl, pH 8.0 at 37°C for 15 min. 202 
Proteins (50 µg) were separated on 8% SDS-PAGE gels (42) and transferred to 203 
polyvinylidene difluoride (PVDF) membranes (Amersham HyBondTM- P, pore size 0.45 µm, 204 
GE Healthcare, Little Chalfont, UK, cat. no. RPN303F) by semi-dry electrotransfer in 0.1 M 205 
Tris, 0.192 M glycine and 5% (v/v) methanol at 2 mA/cm2 for 75 min. Membranes were 206 
stained with 0.5% (w/v) Ponceau S in 1% (v/v) acetic acid for 5 min at RT, destained 3 x 2 207 
min with water, dried on air, and photographed. Membranes were then blocked overnight in 208 
5% (w/v) skimmed milk powder in TBST [20 mM Tris·HCl, pH 7.6 (at RT), 137 mM NaCl, 209 
and 0.1% (v/v) Tween-20] at 4°C and then incubated with a 1:1,000 dilution of rabbit anti-210 
HA antibody (Sigma-Aldrich, Poole, UK, cat. no. H6908, batch no. 015M4868V) in TBST + 211 
5% (w/v) skimmed milk powder for 2 h at RT. Blots were washed four times with TBST and 212 
then probed with a 1:2,000 dilution of anti-rabbit IgG (H+L)-peroxidase conjugate (Cell 213 
Signaling Technology Inc., Danvers, MA, USA, cat. no. 7074S, batch no. 24) in TBST + 5% 214 
(w/v) skim milk powder for 1 h at RT. Blots were then washed four times with TBST and 215 
developed by enhanced chemiluminescence as described before (43). To probe blots for the 216 
actin loading control, blots were stripped after enhanced chemiluminescence detection by 217 
washing them twice for 5 min with 100 mM Tris·HCl, pH 8.5 (at RT) and 0.1% (v/v) Tween-218 
20, twice for 15 min with 100 mM Tris·HCl, pH 8.5 (at RT), 200 mM β-mercaptoethanol, 219 
and 0.1% (v/v) Tween-20, twice for 5 min with TBST, twice for 15 min with 100 mM 220 
glycine, pH 2.5 (at RT) and 0.1% (w/v) Tween-20 at 37°C, and twice for 15 min with TBST. 221 
Blots were then blocked overnight at 4°C with 5% (w/v) skimmed milk powder in TBST and 222 
then incubated for 1 h at RT with a 1:1·105 dilution of a mouse anti-β-actin antibody (Abcam, 223 
Cambridge, UK, cat. no. ab170825, batch no. GR184354-8) in TBST + 5% (w/v) skimmed 224 
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milk powder. Blots were washed four times with TBST, incubated for 1 h at RT with a 225 
1:2·105 dilution of a goat anti-mouse IgG (H+L) peroxidase conjugate (Thermo Fisher 226 
Scientific, Loughborough, UK, cat. no. 31432, batch no. OE17149612) in TBST + 5% (w/v) 227 
skimmed milk powder, washed again four times with TBST, and developed by enhanced 228 
chemiluminescence. Films were scanned on a MFC-5320DW all-in-one printer (Brother 229 
Industries, Manchester, UK) and saved as tif files. Bands were quantified using CLIQS 1.1 230 
(Totallab, Newcastle upon Tyne, UK). 231 
Protein expression and purification. The cytosolic domains of WT and L745A-Ire1 starting 232 
at amino acid 556 were expressed as N-terminal GST fusion proteins from plasmid pGEX-233 
1λT (Genbank accession no. U13849) by autoinduction (44) in E. coli BL21-234 
CodonPlus(DE3)-RIL cells (Agilent Technologies, cat. no. 230240). These constructs 235 
encompass the complete linker, serine/threonine protein kinase, and RNase domains of Ire1. 236 
A ZYM-5052 culture containing 50 µg/ml ampicillin and 25 µg/ml chloramphenicol was 237 
inoculated with 1/1000 volume of a fresh overnight culture grown in MDG medium, grown at 238 
37°C for 5 h and then a further 28 h at 20°C (44). The cells were harvested by centrifugation 239 
at 4,750 g and 4°C for 15 min and washed twice with ice-cold 0.2 M Tris·HCl, pH 8.0 (at 240 
4°C), and finally resuspended in 0.2 M Tris·HCl, pH 8.0 (at 4°C), 0.5 M sucrose, one tablet 241 
of Roche complete protease inhibitors lacking EDTA (Roche Applied Sciences, Burgess Hill, 242 
UK, cat. no. 11873580001), 2 mM PMSF, 6 mM AEBSF, and 1 µg/ml pepstatin. The cells 243 
were lysed by addition of 10 µg/OD600 nm chicken lysozyme (Sigma-Aldrich, cat. no. 62971), 244 
addition of EDTA to a final concentration of 1 mM, dilution of the cell suspension with one 245 
volume of H2O, and incubation of the cell suspension on a roller mixer for 10 min at room 246 
temperature. After addition of 1/10 Vol. of 10% (v/v) Triton X-100 the cell suspension was 247 
sonicated in a Soniprep 150 sonicator (MSE Ltd., London, UK) with a 19 mm diameter probe 248 
in an ice/NaCl bath for twelve cycles of 1 min sonication with an amplitude of 0.22 microns 249 
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followed by a cooling period, in which the cell suspension was allowed to cool to 4°C. The 250 
lysate was then cleared by centrifugation at 40,000 g and 4°C for 15 min. The GST-Ire1 251 
fusion protein was purified by affinity chromatography on GSTrap 4B sepharose columns 252 
(GE Healthcare, cat. no. 28-4017-45) and eluted from the column with 20 mM Tris·HCl, pH 253 
7.5 (at 4°C), 100 mM NaCl, 5% (v/v) glycerol, 0.1% (w/v) CHAPS, 1 mM EDTA, 2 mM 254 
PMSF, and 10 mM glutathione. The eluted protein was concentrated in Amicon Ultra-15 255 
centrifugal filters (MWCO 50 kDa, Merck Millipore, cat. no. UFC905008) and desalted on a 256 
HiTrap desalting column (GE Healthcare, cat no. 17-1408-01). 257 
Mass spectrometric (MS) identification of Ire1 autophosphorylation sites. 5 µg of the 258 
cytosolic domains of WT and L745A-Ire1 expressed as GST fusion proteins in E. coli and 259 
purified by affinity chromatography on GSTrap 4B columns as described above were run on 260 
an 8% SDS-PAGE gel and stained with Coomassie Brilliant Blue R250. Coomassie-stained 261 
protein bands were excised from the gel, transferred to a microtitre plate and destained, buffer 262 
exchanged, reduced with DTT, alkylated with iodoacetamide, and digested with trypsin using 263 
an automated digestion robot (DiGilab, Genomic Solutions, Ann Arbor, MI, USA) as 264 
described before (45). 265 
MS/MS analysis of the cytosolic domains of WT and mutant Ire1 expressed in E. coli was 266 
carried out on an LTQ XL orbitrap mass spectrometer (Thermo Scientific) coupled to an 267 
Ultimate 3000 nano HPLC system. The RP-LC system consisted of a desalting column (300 268 
µm x 5 mm, PepMap C18 3 µm, 100 Å) and an analytical column (75 µm x 250 mm, 269 
PepMap C18 3 µm, 100 Å) with split solvent delivery (split ratio 1:300). A Thermo 270 
nanospray II source was fitted with a 30 µm silica emitter tip (PicoTip, New Objective, US) 271 
and maintained at 1100 V ion spray voltage. Peptide samples (3 µl) were loaded onto the trap 272 
column in 0.1% (w/v) trifluoroacetic acid at 20 µl/min for 3 min and eluted at 300 nl/min 273 
using a gradient from 0.05% (v/v) formic acid in water (A) to 0.05% formic acid in 80% (v/v) 274 
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acetonitrile (B). The gradient profile was as follows: 4% buffer B for 3 min, 4% B to 40% B 275 
in 40 min, 40% B to 65% B in 6 min, 65% B to 95% B in 1 min, and 95% B for 6 min. Using 276 
Excalibur 2.0.1, intact peptides were detected between m/z 400 and m/z 1,600 in the orbitrap 277 
at a resolution of 60,000. Internal calibration was performed using the ion signal of 278 
(Si(CH3)3O)6H+ at m/z 445.120025 as a lock mass (46). Maximum ion accumulation time 279 
allowed on the LTQ orbitrap was 1 s for all scan modes. Automatic gain control was used to 280 
prevent over-filling of the ion trap. Collision induced dissociation (CID) spectra of the top 5 281 
peptide ions (minimum intensity 10,000 counts, rejection of singly charged precursors) were 282 
acquired at a normalised collision energy of 35. Dynamic exclusion was set with a repeat 283 
count of 1, a repeat time of 30 s and, an exclusion time of 3 min and an exclusion list size of 284 
50. The chromatography feature was enabled with a correlation area ratio of 1.0. Activation 285 
Q was set to 0.25 with 30 ms activation time. 286 
XITandem tornado version 2009.04.01.1 (47) was used to search the ENSEMBL yeast 287 
proteome database (version SGD1.01.55) and the common repository of adventitious proteins 288 
(cRAP, http://www.theqpm.org/crap/index.html) for the identification of proteins and the 289 
reversed version of both databases. Precursor mass accuracy was set to 20 ppm and fragment 290 
mass error to 0.6 Da. Carbamidomethylation of cysteine was set as a fixed modification and 291 
phosphorylation of serine, threonine and tyrosine as a variable modification. At the 292 
refinement step, oxidation of methionine and tryptophan, double oxidation of methionine and 293 
tryptophan, deamidation of asparagine and glutamine, methylation of aspartate, glutamate, 294 
histidine, lysine, arginine and asparagine, carbamidomethylation of lysine, histidine, aspartate 295 
and glutamate and dehydration of serine and threonine were included in the search 296 
parameters. At a cutoff loge value of 1.0, searching the decoy databases indicated a false 297 
discovery rate between 1.18% and 1.39% for protein identification. Detailed results and all 298 
spectra can be accessed via the following links: WT - http://human.thegpm.org/thegpm-299 
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cgi/plist.pl?path=/tandem/archive/GPM28700000061.xml and L745A - 300 
http://human.thegpm.org/thegpm-cgi/plist.pl?path=/tandem/archive/GPM28700000059.xml. 301 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 302 
Consortium via the PRIDE (48) partner repository with the dataset identifier PXD004924. 303 
Confocal fluorescence microscopy. Cells grown to mid-exponential growth phase in SD 304 
medium lacking leucine and uracil and supplemented with 100 mg/l adenine and 100 mg/l L-305 
tryptophan were concentrated ~60 fold in SD medium lacking leucine and uracil and 306 
supplemented with 100 mg/l adenine and 100 mg/l L-tryptophan before addition of 2 mM 307 
DTT. 5 µl of untreated cell suspensions or cell suspensions exposed to 2 mM DTT were 308 
examined on a Zeiss LSM 880 with Airyscan confocal inverted microscope (Carl Zeiss Ltd. 309 
Cambridge, UK) using a Plan-Apochromat 63x/1.4 Oil DIC M27 objective and a MDS 310 
488/594 beam splitter. GFP fluorescence was excited with a 488 nm laser at a power setting 311 
of 5 – 8% and its fluorescence emission was collected between 498 to 564 nm with a 312 
photomultiplier tube. mCherry fluorescence was excited with a 594 nm laser at a power 313 
setting of 28 – 40% and its fluorescence emission was collected at 694 – 754 nm with a 314 
gallium arsenide phosphide detector. Gain settings between 650 and 900 were used to collect 315 
images. 316 
Statistical analyses. Experimental data are presented as the mean and its standard error. For 317 
composite parameters, errors were propagated using the law of error propagation for random, 318 
independent errors (49). All data were analysed for normality using the D’Agostino-Pearson 319 
omnibus normality test (50), equality of variances (homoscedasticity) using the Brown-320 
Forsythe test (51) or Bartlett’s test (52), and for additivity of means, treatment effects, and 321 
errors using Tukey’s test (53, 54) before ANOVA. Heteroscedastic or nonadditive data were 322 
ln-transformed before ANOVA (53) or analysed by Welch’s test (55) followed by the 323 
Games-Howell post-hoc test (56). Normality was examined on the pooled data for the ire1∆ 324 
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deletion strain transformed with YCplac33 or, alternatively, on all pooled data points before 325 
induction of ER stress. In all analyses P ≤ 0.05 was considered to be statistically significant. 326 
Brown-Forsythe tests for equality of variances, Tukey’s test for additivity, Welch’s tests, and 327 
Games-Howell post hoc tests were performed in Microsoft Excel 2010 (Microsoft 328 
Corporation, Redmond, WA, USA) using the Real Statistics plug-in for Microsoft Excel 329 
(http://www.real-statistics.com/). All other statistical calculations were performed in 330 
GraphPad Prism 6.07 (GraphPad Software, La Jolla, CA, USA). 331 
Results 332 
S837 is a potential autophosphorylation site. To identify autophosphorylation sites in the 333 
activation segment of Ire1, we expressed the cytosolic portion of Ire1 starting at Q556 as an 334 
N-terminal glutathione S transferase fusion protein in E. coli, purified it by affinity 335 
chromatography on glutathione sepharose beads and analysed tryptic digests by tandem mass 336 
spectrometry. Four peptides that cover the activation segment from L835 to R856 carrying 337 
one phosphoryl group at S841 (spectrum 1155, data not shown), two phosphoryl groups at 338 
S841 and T844 (spectrum 1475, data not shown), three phosphoryl groups at S840, S841, and 339 
S850 (spectrum 1976, Fig. 2A), and three phosphoryl groups at S840, T844, and S850 340 
(spectrum 2031, Fig. 2B) were identified. In addition, a shorter peptide starting at T844 and 341 
carrying one phosphoryl group at S850 was identified (spectra 760 and 816, data not shown). 342 
These autophosphorylation sites in the activation segment of WT Ire1 correspond to 343 
previously reported autophosphorylation sites in the activation segment (18). 344 
We also characterised autophosphorylation of an L745A mutant of Ire1, which possesses 345 
an enlarged ATP binding pocket to accommodate chemically-modified, bulkier adenine 346 
moieties (57, 58). In vivo, L745A-Ire1 supports induction of an UPRE-lacZ reporter to ~60% 347 
of WT levels (23), which suggests that this mutant possesses significant protein kinase and 348 
RNase activities. MS/MS analyses of tryptic peptides derived from the L745A mutant 349 
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identified several peptides that cover the activation segment from L835 to R856. One carried 350 
three phosphoryl groups at S840, S841, and T844 (spectrum 1583, data not shown), another 351 
carried four phosphoryl groups at S840, S841, T844, and S850 (spectrum 2251, data not 352 
shown), and a third one also carried four phosphoryl groups (spectrum 2263, data not shown). 353 
Of these, three could be unambiguously assigned to S840, S841, and T844, while the forth 354 
phosphoryl group is located on S850 or T852. No peptide allowed unambiguous assignment 355 
of a phosphoryl group to T852. A peptide that covers the activation segment from K834 to 356 
R856 carried two phosphoryl groups at S837 and T844, one phosphoryl group at S840 or 357 
S841 and another phosphoryl group at S850, T852, or S853 (spectrum 1462, Fig. 2C). 358 
Evidence for phosphorylation at S837 is provided by the m/z ratio of the +1b ion of m/z 359 
709.033 Da, which exceeds the m/z ratio for the unphosphorylated peptide by 79.7 Da. This 360 
difference matches, within the measurement error of 0.6 Da, the mass difference between a 361 
phosphorylated and unphosphorylated peptide. In addition to peptides carrying multiple 362 
phosphoryl groups two monophosphorylated peptides, one covering the activation segment 363 
from L835 to R843 and being phosphorylated at S841 (spectrum 152, data not shown) and 364 
one covering the activation segment from T844 to R856 and being phosphorylated at S850 365 
(spectra 488 and 540, data not shown) were detected. These data show that 366 
autophosphorylation of WT and L745A Ire1 in the activation segment strongly overlap and 367 
raise the possibility that S837 is an additional autophosphorylation site in the activation 368 
segment of Ire1. 369 
Mutation of all phosphorylation sites in the activation segment decreases, but does not 370 
eliminate, HAC1 splicing, induction of ER chaperone genes, and survival of ER stress. To 371 
evaluate the contribution of S837 to activation of Ire1 we characterised the ER stress 372 
response of three Ire1 mutants, S840A S841A, S840A S841A T844A S850A (brief: Q-A), 373 
and S837A S840A S841A T844A S850A (brief: P-A). A time course experiment revealed 374 
 17 
 
 
 
that HAC1 splicing reaches steady-state levels as early as 15 min after induction of ER stress 375 
with 2 mM DTT in cells in the mid-exponential growth phase (Fig. 3A-C). An increase in 376 
HAC1 splicing 15 min after induction of ER stress was detectable in all three mutants, but 377 
was quantitatively lower than in cells expressing WT Ire1. Differences between the three 378 
phosphorylation site mutants were not statistically significant (Fig. 3B, C). 2 h after induction 379 
of ER stress the difference between cells lacking Ire1 and cells expressing either S840A-380 
S841A-Ire1 or Q-A-Ire1 were statistically significant (Fig. 3B, C), whereas the difference 381 
between cells lacking Ire1 and cells expressing P-A-Ire1 did not become statistically 382 
significant (Fig. 3B, C). These two comparisons, cells expressing P-A-Ire1 to cells expressing 383 
S840A-S841A- or Q-A-Ire1 and cells expressing P-A-Ire1 to cells lacking Ire1, suggest that 384 
S837 may make a minor contribution to activation of Ire1. 385 
The differences in HAC1 splicing were reflected by the induction of KAR2 and PDI1 386 
mRNAs. Induction of both mRNAs kinetically trailed HAC1 splicing and reached a 387 
maximum only after ~1 h of ER stress (Fig. 3A, D-E). All three phosphorylation site mutants 388 
induced both KAR2 and PDI1 mRNAs to similar levels, which remained, especially in the 389 
case of KAR2 mRNA, below the level of induction reached in cells expressing WT Ire1. 2 h 390 
after induction of ER stress with 2 mM DTT KAR2 mRNA, but not PDI1 mRNA levels, were 391 
significantly increased in all autophosphorylation site mutants when compared to cells 392 
lacking Ire1, suggesting that even P-A-Ire1 can partially activate expression of KAR2 in ER-393 
stressed cells. 394 
Next, we compared expression of an UPRE-lacZ reporter between cells expressing the 395 
different autophosphorylation site mutants, because accumulation of the comparatively stable 396 
protein β-galactosidase (59) may reveal subtle differences in transduction of the ER stress 397 
signal. All three autophosphorylation site mutants induced expression of the reporter, but to a 398 
lower degree than cells expressing WT Ire1 (Fig. 4A, B). This observation suggests that Ire1 399 
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can transduce an ER stress signal in the absence of autophosphorylation in its activation loop. 400 
Induction of the lacZ reporter was stronger in cells expressing S840A-S841A-Ire1 than in 401 
cells expressing either Q-A- or P-A-Ire1 (Fig. 4A), which supports the conclusion that 402 
phosphorylation of S837, T844, or S850 contributes to activation of Ire1 at least when 403 
phosphorylation at S840 and S841 is no longer possible. 404 
To explore the possibility that decreased HAC1 splicing and KAR2 and PDI1 mRNA 405 
induction by activation loop mutants is caused by a defect in clustering of Ire1 in vivo (5), we 406 
monitored foci formation by WT and mutant Ire1 fused to the fluorescent protein mCherry 407 
before and after induction of ER stress with 2 mM DTT for 15 min or 60 min. Before 408 
induction of ER stress Ire1-mCherry displayed a distribution characteristic for an ER protein 409 
with areas of fluorescence around the nucleus and the cell surface, which are indicative of the 410 
perinuclear and cortical ER (Fig. 5). This distribution also overlapped with the distribution of 411 
a fluorescent marker for the ER, a fusion of GFP to the C-terminus of the Sec63 subunit of 412 
the protein translocation channel of the ER membrane (24). In addition to this ER 413 
localisation, cells carrying WT and mutant IRE1 alleles also showed a distinct intracellular 414 
mCherry fluorescence that filled most of the cell body (Fig. 5). This mCherry fluorescence 415 
colocalises with the fluorescence of the vacuolar stain 7-amino-4-chloromethylcoumarin 416 
(data not shown). As early as 15 min after induction of ER stress with 2 mM DTT, a 417 
characteristic punctuate fluorescence developed for the mCherry, but not the GFP 418 
fluorescence in cells expressing WT Ire1-mCherry. This punctuate fluorescence is indicative 419 
of clustering of Ire1 in vivo in the ER membrane (5). 1 h after DTT treatment most of the 420 
mCherry fluorescence localises to clusters (Fig. 5). There were no noticeable differences in 421 
the development of punctuate mCherry fluorescence in cells expressing activation loop 422 
mutants of Ire1 fused to mCherry (Fig. 5). These experiments suggest that activation loop 423 
mutants do not display a defect in clustering in vivo. 424 
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To evaluate whether the weak ER stress response of the phosphorylation site mutants 425 
suffices to survive ER stress, we characterised the survival of these mutants under conditions 426 
of low levels of ER stress. Consistent with the gene expression data, all phosphorylation site 427 
mutants displayed a small degree of protection against ER stress, as evidenced by their 428 
improved growth on plates containing 0.4 µg/ml tunicamycin when compared to cells lacking 429 
Ire1 (Fig. 6). At higher concentrations of tunicamycin this growth advantage of the 430 
phosphorylation site mutants over the IRE1 deletion strain was diminished. Activation loop 431 
mutants express to levels comparable to WT Ire1 in both the S288C and W303 genetic 432 
backgrounds (Fig. 7 and data not shown), which suggests that the partial defect in responding 433 
to ER stress displayed by activation loop mutants cannot be explained by decreased 434 
intracellular abundance of mutant Ire1 proteins. In summary, these data show that all three 435 
autophosphorylation site mutants can activate a weak, but physiologically significant, ER 436 
stress response. 437 
D836 is required for the ER stress response mediated by phosphorylation site mutants. The 438 
activation loop of Ire1 features an aspartate that has been functionally conserved throughout 439 
evolution in fungal and plant Ire1 (Fig. 1). Phosphorylation-independent RD kinases can 440 
employ a negatively charged glutamate located in the activation loop to stabilise the basic 441 
pocket formed by the invariant arginine and the basic amino acid located in strand β9 (20). 442 
For example, in phosphorylase kinase glutamate 182 neutralises the invariant arginine that 443 
precedes the catalytic aspartate (60). Mutation of this glutamate to serine decreases catalytic 444 
efficiency ~20 fold (61). In partially active human CDK2-cyclin A complexes the basic 445 
pocket is stabilised by interaction with glutamate 162 (62). For these reasons, we introduced a 446 
D836A mutation into WT Ire1 and the three phosphorylation site mutants and compared the 447 
ER stress response of these mutants to the ER stress response of WT Ire1, S840A-S841A-448 
Ire1, Q-A-Ire1, and P-A-Ire1. 449 
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Splicing of HAC1 mRNA and induction of both KAR2 and PDI1 mRNA were monitored 450 
in time course experiments similar to the experiments described above. Introduction of the 451 
D836A mutation into WT Ire1 had no effect on HAC1 splicing or induction of KAR2 and 452 
PDI1 mRNAs (Fig. 8). By contrast, introduction of the D836A mutation into S840A-S841A-453 
Ire1, Q-A-Ire1, or P-A-Ire1 resulted in a virtually complete loss of HAC1i mRNA and 454 
abrogated induction of KAR2 mRNA (Fig. 8). PDI1 mRNA no longer increased to levels 455 
significantly above levels seen in cells deleted for IRE1. Despite of the absence of HAC1i 456 
mRNA, faint bands representing cleavage intermediates, such as the 1st exon of HAC1u 457 
mRNA plus the intron and the 1st exon of HAC1u mRNA could still be observed in cells 458 
expressing D836A-S840A-S841A-, D836A-Q-A-, or D836A-P-A-Ire1 (Fig. 8A). 459 
Introduction of the D836A mutation nearly completely eliminated expression of 460 
β-galactosidase from UPRE-lacZ reporters when introduced into S840A-S841A- and Q-A-461 
Ire1 (Fig. 9). Introduction of the D836A mutation into P-A-Ire1 further decreased expression 462 
of β-galactosidase 2 h after induction of ER stress with 2 mM DTT (from 11.2 ± 1.6 U/g to 463 
5.6 ± 1.4 U/g) to levels very close to and statistically undistinguishable from levels seen in 464 
IRE1 deletion strains exposed to ER stress for 2 h (2.7 ± 0.4 U/g), but this decrease did not 465 
reach statistical significance. Differences in expression levels of the β-galactosidase reporter 466 
in IRE1 deletion cells, cells expressing D836A-S840A-S841A-, D836A-Q-A-, or D836A-P-467 
A-Ire1 were not statistically significant (Fig. 7). The D836A mutation, however, did not 468 
affect expression of β-galactosidase when introduced into WT Ire1 (Fig. 9). The D836A 469 
mutation did also not affect clustering of Ire1 in vivo, either in the context of otherwise WT 470 
Ire1 or the activation loop mutants (Fig. 10), or steady-state expression levels of Ire1 (Fig. 7). 471 
Introduction of the D836A mutations into the phosphorylation site mutants resulted in growth 472 
phenotypes very similar to the growth phenotypes of IRE1 deletion cells (Fig. 11), but, as in 473 
the case of the gene expression data the D836A mutation by itself did not decrease survival of 474 
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ER stress induced with tunicamycin or DTT (Fig. 11). Taken together, these data support the 475 
conclusion that D836 is required for the residual ER stress response only when activation 476 
loop phosphorylation is impaired. 477 
Activation loop mutants do not affect inactivation of Ire1. To investigate whether mutations 478 
in the activation loop affect the inactivation of Ire1, we characterised the decay of HAC1 479 
splicing, KAR2 and PDI1 mRNA after washout of DTT from cells exposed to 2 mM DTT for 480 
2 h. The percentage of HAC1i mRNA, the percentage of HAC1 mRNA cleavage, KAR2 and 481 
PDI1 mRNA levels decayed with first order kinetics (Fig. 12). The lower maximal responses 482 
of the S840A S841A, Q-A, and P-A mutants to 2 mM DTT (Figs. 3, 8, and 12) allow these 483 
mutants to return to basal levels of HAC1 splicing, KAR2 and PDI1 mRNA levels earlier than 484 
cells expressing WT and D836A-Ire1 (Fig. 12). We did not find any statistically significant 485 
differences in the decay rates for any of the Ire1 mutants in an ordinary one way ANOVA 486 
with Tukey’s correction for multiple comparisons. Likewise, no obvious differences between 487 
WT Ire1 and any Ire1 mutants in the dissolution of Ire1 clusters at the ER membrane were 488 
observed (Fig. 5 and Fig. 10). These data suggest that inactivation of Ire1 is independent of 489 
D836 and phosphorylation sites in the activation loop. 490 
Negative regulation of Ire1 by the phosphatase Ptc2 requires phosphorylation sites in the 491 
activation loop of Ire1. The identical inactivation kinetics for WT Ire1 and activation loop 492 
mutants prompted us to characterise whether two negative regulators of Ire1, the 493 
phosphatases Dcr2 (30) and Ptc2 (31), negatively regulate Ire1 through its activation loop. 494 
Overexpression of Ptc2 from the GAL1 promoter on a 2 µ plasmid inhibited growth (31). 495 
Overexpression of WT Ptc2, but not catalytically inactive E37A-D38A- or D234A-Ptc2, also 496 
inhibited growth of cells exposed to a low concentration tunicamycin (31). Consistent with 497 
this earlier report, we find that overexpression of Ptc2 from the GAL1 promoter on the 2 µ 498 
plasmid pRSII422 inhibited growth of unstressed cells (Fig. 13A). Overexpression of 499 
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catalytically inactive E37A-D38A-Ptc2 also inhibited growth of unstressed cells, but to a 500 
lesser extent than overexpression of WT Ptc2 (Fig. 13A). Deletion of IRE1 slightly impaired 501 
growth of unstressed cells on raffinose and galactose, but also masked the negative effects of 502 
expression of WT or E37A-D38A-Ptc2 on growth of unstressed cells (Fig. 13A). Likewise, 503 
expression of D836A-P-A-Ire1 masked the negative effects of expression of WT or E37A-504 
D38A-Ptc2 on growth of unstressed cells, suggesting that WT and E37A-D38A-Ptc2 act 505 
through Ire1 to inhibit growth of unstressed cells. 506 
These genetic interactions between IRE1 and PTC2 in unstressed cells complicate the 507 
interpretation of effects of overexpression of Ptc2 in ER-stressed cells expressing different 508 
IRE1 alleles. Therefore, we semiquantitatively scored the effects of overexpression of Ptc2 on 509 
survival of ER stress by calculating the differences between the maximum dilutions at which 510 
growth of more than two cells can be observed for ER-stressed and unstressed cells. This 511 
scoring system revealed that expression of WT Ptc2, but not E37A-D38A-Ptc2, in cells 512 
expressing WT or D836A-Ire1 impaired growth in the presence of ER stress induced with 0.8 513 
µg/ml tunicamycin (Fig. 13A). This observation is consistent with the earlier finding that 514 
overexpression of WT, but not catalytically inactive Ptc2, inhibited growth of ER-stressed 515 
cells (31). The negative effects of overexpression of WT Ptc2 on growth of ER-stressed cells 516 
were abrogated in ire1∆ cells or cells expressing P-A- or D836A-P-A-Ire1 (Fig. 13A). These 517 
data show that deletion of IRE1 or expression of a mutant in which all potential 518 
phosphorylation sites in the activation loop have been mutated to alanine mask the effects of 519 
overexpression of WT Ptc2 on growth of ER-stressed cells. 520 
Overexpression of Dcr2 by placing the GAL1 promoter in front of the chromosomal 521 
DCR2 gene was reported to inhibit growth when ER stress was induced with tunicamycin 522 
(30). In contrast to this finding, we did not observe any inhibition of growth by 523 
overexpression of Dcr2 using a similar expression system (Fig. 13B). We then explored 524 
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whether further elevation of Dcr2 levels by expressing Dcr2 from the GAL1 promoter on the 525 
2 µ plasmid pRSII422 affects growth of ER-stressed cells, because overexpression of Ptc2 526 
from the GAL1 promoter on a 2 µ plasmid inhibited growth of ER-stressed cells (Fig. 13A) 527 
while overexpression of Ptc2 by placing the GAL1 promoter in front of the chromosomal 528 
PTC2 gene had no effect of growth of ER-stressed cells (data not shown). Overexpression of 529 
WT Dcr2 and catalytically inactive H338A-Dcr2 (63) from the GAL1 promoter on a 2 µ 530 
plasmid inhibited growth of unstressed WT cells to the same extent, but did not affect 531 
survival of ER stress (Fig. 13C). Deletion of IRE1 slightly impaired growth on raffinose and 532 
galactose (Fig. 13C) and largely masked the negative effects of expression of WT and 533 
H338A-Dcr2 on growth of unstressed cells (Fig. 13C). Expression of WT or H338A-Dcr2 did 534 
not alter survival of ER stress by ire1∆ cells (Fig. 13C). These data suggest that 535 
overexpression of Dcr2 does not affect survival of ER stress. 536 
To characterise whether deletion of DCR2 or PTC2 affects survival of ER stress we 537 
constructed dcr2∆ and ptc2∆ strains, and double dcr2∆ ptc2∆ strains. Survival of ER stress 538 
was not altered by deletion of DCR2, deletion of PTC2, or by simultaneous deletion of both 539 
DCR2 and PTC2 (Fig. 13D). These data suggest that negative regulation of Ire1 by Dcr2 and 540 
Ptc2 to optimally tune the amplitude of the Ire1 signalling output is not required to survive 541 
ER stress or that other phosphatases exist that can compensate for the loss of both Dcr2 and 542 
Ptc2 in dcr2∆ ptc2∆ cells. 543 
Discussion 544 
The data presented here show that Ire1 can transduce a partial ER stress signal in the absence 545 
of phosphorylation in its activation loop (Figs. 3 and 4). The partial activation of HAC1 546 
splicing by activation loop mutants resulted in partial induction of KAR2 and PDI1 mRNAs 547 
(Fig. 3D, E) and partial protection from ER stress (Fig. 6). In addition, we show that 548 
transduction of this partial ER stress signal by activation loop mutants relies on the presence 549 
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of a negatively charged amino acid such as an aspartate or a glutamate in the activation loop, 550 
which has been conserved throughout evolution in fungal and plant Ire1 (Fig. 1). Mutation of 551 
this aspartate, D836 in S. cerevisiae Ire1, to alanine in activation loop mutants nearly 552 
completely eliminated production of HAC1i mRNA, induction of KAR2 and PDI1 mRNA, of 553 
an UPRE-lacZ reporter, and survival of ER stress (Figs. 8, 9 and 11). In this way, 554 
introduction of the D836A mutation into activation loop mutants is reminiscent of the in vitro 555 
behaviour of human IRE1α. IRE1α lacks negatively charged amino acids in its activation 556 
loop (Fig. 1A) and displayed a ~100-fold increase of its Vmax and kcat upon phosphorylation 557 
(22). By contrast, the D836A mutation by itself had no effect, because the levels of HAC1 558 
splicing, induction of KAR2 and PDI1 mRNA and of the UPRE-lacZ reporter, and survival of 559 
ER stress were indistinguishable from cells expressing WT Ire1. These observations suggest 560 
that D836 can partially substitute for activation loop phosphorylation in the activation loop 561 
mutants. 562 
The role of activation loop phosphorylation in activation of Ire1 is thought to lie in 563 
conformational changes in the activation loop that result in opening of the ATP binding 564 
pocket (18). Binding of ATP then induces oligomerisation of Ire1 and RNase activity (18). In 565 
this model for activation of Ire1, point mutations in the protein kinase domain, that largely 566 
inactivate the protein kinase activity of Ire1, should display a significant loss of RNase 567 
activity. However, mutation of D828, which contributes to coordinating two Mg2+ ions 568 
important for catalysis of the γ-phosphoryl transfer reaction, or mutation of the catalytic 569 
aspartate, D797, did not destroy RNase activity (7, 21). Retention of RNase activity by these 570 
protein kinase mutants may, as in the case for the activation loop mutants, be explained by 571 
the presence of D836 in the activation loop. 572 
Based on its primary amino acid sequence, Ire1 belongs to the family of RD kinases and 573 
its reliance on activation loop phosphorylation for full activity [Figs. 2 and 3 and (22)] 574 
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suggests that Ire1 belongs to the family of phosphorylation-dependent RD protein kinases. In 575 
these protein kinases phosphoamino acids in the activation loop move into a basic pocket 576 
formed by the invariant arginine that precedes the catalytic aspartate (R796 in S. cerevisiae 577 
Ire1) and a second basic amino acid located in strand β9 (K833 on strand β10 in Ire1). The 578 
crystal structure of oligomeric Ire1 shows phosphorylated T844 in contact with this basic 579 
pocket (4), as would be expected for a phosphorylation-dependent RD kinase. However, 580 
phosphorylation at T844 is of lesser importance than phosphorylation at S840 or S841, 581 
because induction of both KAR2 and PDI1 mRNAs was more severely affected in the S840A 582 
S841A double mutant than the T844A single mutant (3). The importance of S840 or S841 in 583 
activation of Ire1 is further supported by the observation that all phosphorylation site mutants 584 
show a similar decrease in HAC1 splicing and induction of both KAR2 and PDI1 (Fig. 3). 585 
This suggests that the other phosphorylation sites may only play minor roles or require the 586 
presence of S840 or S841 to mediate activation of the endoribonuclease domain. Data 587 
obtained from the β-galactosidase reporter assays (Fig. 4) indicate that the other 588 
phosphorylation sites can mediate some activation of the endoribonuclease domain 589 
independent of S840 or S841. Introduction of the D836A mutation into any of the three 590 
phosphorylation site mutants nearly completely abolished HAC1 splicing, induction of KAR2, 591 
PDI1, and the β-galactosidase reporter, and survival of ER stress (Figs. 8, 9, and 11). This 592 
behaviour of the D836A mutation suggests that the residual ER stress response transduced by 593 
S840A-S841A-Ire1 relies on D836 and that D836 can partially substitute for functions 594 
provided by S840 or S841 in WT Ire1. In the absence of D836, S840 and S841 the other 595 
phosphorylation sites can no longer mediate effective activation of Ire1 (Figs. 8, 9, and 11), 596 
which suggests that a function provided by D836, S840 or S841 is necessary for activation of 597 
Ire1. At the same time, induction of the β-galactosidase reporter decreases from S840A-598 
S841A-Ire1, to Q-A-Ire1, and P-A-Ire1 (Fig. 4), which suggests that the ability of D836 to 599 
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mediate activation of Ire1 requires at least one of the other phosphorylation sites. These data 600 
are consistent with the view that the activation loop makes at least two contacts necessary for 601 
activation of Ire1, one mediated by S840 or S841, and in their absence, and to a lesser degree, 602 
by D836, and a second one mediated by one of the other phosphorylation sites. 603 
The crystal structure of oligomeric Ire1 suggests that two contacts of the activation loop 604 
necessary for activation of Ire1 are made between phosphorylated S840 and S841 and R896 605 
of the same molecule and K678 of an adjacent Ire1 molecule, and between phosphorylated 606 
T844 and the RD pocket (4). D836 may simply substitute for S840 and S841 by contacting 607 
the same basic pocket, while phosphorylated T844 still remains in contact with the RD 608 
pocket, but it is also possible that D836 contacts the RD pocket and that phosphorylated 609 
T844, phosphorylated S837, or phosphorylated S850 contact the basic pocket formed by 610 
R896 and K678 in S840A S841A mutants. Contacts made between the phosphorylated 611 
activation loop and basic pockets have been proposed to facilitate oligomerisation of Ire1 (4). 612 
In vivo clustering of Ire1, however, was not affected by the activation loop mutants (Fig. 5) or 613 
by introduction of the D836A mutation into any of the activation loop mutants (Fig. 10). 614 
These observations suggest that surfaces other than the phosphorylated activation loop suffice 615 
to mediate efficient clustering of Ire1 in vivo. Therefore, it seems that the critical roles of 616 
activation loop phosphorylation in activation of Ire1 may not lie in facilitating clustering of 617 
Ire1. 618 
D836 can only partially substitute for phosphorylation of S840 or S841, because all 619 
activation loop mutants can only support levels of HAC1 splicing that are significantly lower 620 
than in cells expressing WT Ire1. This may be due to the decreased negative charge of a 621 
carboxylate when compared to a phosphate and subsequent partial neutralisation of positive 622 
charges in basic pockets, such as the basic pocket formed by R896 and K678 of an adjacent 623 
Ire1 molecule, resulting in decreased stability of active conformations. In addition, steric 624 
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constraints may prevent the smaller aspartate to move as close to positive charges as 625 
phosphoamino acids might, which again may destabilise active conformations. Furthermore, 626 
D836 can only make one contact to basic pockets, whereas, for example, phosphorylated 627 
S840 and S841 can make two contacts to the same basic pocket (4). The lack of a phenotype 628 
for cells expressing D836A-Ire1 suggests that conformations formed by phosphorylated Ire1 629 
are more stable or longer-lived than any conformations in which D836 attempts to take over 630 
any roles of phosphorylation. Alternatively, phosphorylation may be kinetically 631 
outcompeting formation of any conformations in which D836 replaces phosphoserines or 632 
phosphothreonines. 633 
Inactivation of Ire1 is thought to involve its dephosphorylation (21, 22), but also its 634 
autophosphorylation in its αEF insertion loop (7, 21). The similar inactivation kinetics of WT 635 
Ire1 and activation loop mutants (Fig. 12) suggests that inactivation of Ire1 is a twostep 636 
process in which fast dephosphorylation of Ire1 precedes slower, phosphorylation-637 
independent steps (Fig. 12). In the DTT wash-out experiments (Fig. 12) only the slower 638 
phosphorylation-independent steps may have been observed. These phosphorylation-639 
independent steps may represent the reassociation of Kar2 with the luminal domain of Ire1 640 
(64-67), the disassembly of Ire1 oligomers, or the clearance of misfolded and damaged 641 
proteins from the ER via ER-associated degradation or dilution by growth. We observed no 642 
noticeable differences in the disassembly of Ire1 foci in cells expressing WT Ire1, 643 
phosphorylation site mutants (Fig. 5), or a combination of phosphorylation site mutants and 644 
the D836A mutation (Fig. 10). Thus, while activation of Ire1 leading to HAC1 splicing 645 
requires at least one negative charge in the activation loop, inactivation of Ire1 and 646 
dissolution of Ire1 clusters proceeds independent of negative charges on the activation loop. 647 
The initial, fast dephosphorylation in the inactivation of Ire1 may be mediated by the 648 
phosphatases Dcr2 (30) or Ptc2 (31). Overexpression of Ptc2 in cells expressing different 649 
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IRE1 alleles revealed that deletion of IRE1 or expression of IRE1 alleles that lack all potential 650 
phosphorylation sites mask the effects of overexpression of Ptc2 (Fig. 13A). These findings 651 
are consistent with the view that Ptc2 may attenuate Ire1 signalling by dephosphorylating the 652 
activation loop of Ire1, resulting in decreased levels of HAC1 splicing (31). However, 653 
decreased phosphorylation of the activation loop in activation loop mutants may impair ATP 654 
binding (18) and decrease the protein kinase activity of Ire1 leading to decreased 655 
phosphorylation of other regions of Ire1 such as its αEF insertion loop. Therefore, the 656 
epistatic relationship between Ire1 and Ptc2 may also be explained by dephosphorylation of 657 
regions other than the activation loop by Ptc2. In contrast to Ptc2, we found no evidence that 658 
overexpression of Dcr2 affects survival of ER stress (Fig. 13B, C). We also do not observe a 659 
synthetic growth defect in ire1∆ dcr2∆ cells (Fig. 13D) or that deletion of DCR2 impairs 660 
survival of ER stress which contrasts to previously reported results (30). While these different 661 
results may be explained by the different genetic backgrounds, W303 and S288c, used in the 662 
two studies, we also did not observe any effects of overexpression of Dcr2 from the GAL1 663 
promoter on the 2 µ plasmid pRS425 in the S288c genetic background (data not shown). 664 
Deletion of IRE1 or expression of D836A-P-A-Ire1 also masks the toxic effects of 665 
overexpression of WT and catalytically inactive Ptc2 and Dcr2 on growth of unstressed cells 666 
(Fig. 13A, C). For PTC2 similar epistatic relationships to IRE1 seem to exist in unstressed 667 
and ER-stressed cells, suggesting that Ptc2 may act through the same mechanism in 668 
unstressed and ER-stressed cells. It is unlikely that unmasking of the inositol auxotrophy of 669 
ire1∆ cells (68) by overexpression of Ptc2 can explain the growth inhibitory effects of Ptc2, 670 
because increasing the inositol concentration did not mitigate the growth inhibitory effects of 671 
overexpression of Ptc2 (data not shown). Deletion of IRE1 is also epistatic to overexpression 672 
of Dcr2 in unstressed cells (Fig. 13C). The lack of any effect of overexpression of DCR2 on 673 
growth in the presence of ER stress suggests another genetic relationship between IRE1 and 674 
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DCR2 than between IRE1 and PTC2. Deletion of IRE1 may, for example, perturb a secretory 675 
pathway function that is located upstream of a secretory pathway function of Dcr2. 676 
In summary, our work shows that yeast Ire1 retains the ability to transduce a weak ER 677 
stress signal when all its phosphorylation sites in its activation have been mutated to alanine. 678 
The ability of these activation loop mutants to respond to ER stress relies on the presence of a 679 
negatively charged amino acid in the activation loop. These findings provide a molecular 680 
explanation for some of the differences between yeast and mammalian Ire1. 681 
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Figure legends 884 
Figure 1. Sequence alignment of the activation segment of Ire1. The GenBank accession 885 
numbers are: Arabidopsis thaliana 1 - NP_568444, A. thaliana 2 - NP_565419, Ashbya 886 
gossypii - NP_984389, Aspergillus fumigatus - XP_749922, Caenorhabditis elegans - 887 
AAL30828, Candida albicans - XP_717532, Drosophila melanogaster - NP_001097839, 888 
Homo sapiens α - NP_001424; H. sapiens β - NP_150296, Saccharomyces cerevisiae - 889 
NP_011946, and Trichoderma reesei - AAP92915. The sequence for Saccharomyces bayanus 890 
Ire1 was obtained from the Saccharomyces genome database. Amino acids in the activation 891 
loop are shown in blue, potential phosphoacceptor sites in red, and aspartic and glutamic acid 892 
in orange. 893 
Figure 2. Ire1 autophosphorylates at S837. (A) Fragmentation spectrum 1976 for the 894 
peptide 835LDSGQpSpSFRTNLNNPpSGTSGWR856 derived from WT Ire1. Detected mass to 895 
charge ratios for the +1y (red) and +2y (blue) ion series are shown. Brackets highlight 896 
fragmentations that are explained by the presence of phosphoryl groups. The difference 897 
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between the observed mass to charge ratio and the monoisotopic mass to charge ratio for the 898 
unphosphorylated ions are indicated. (B) Fragmentation spectrum 2031 for the peptide 899 
835LDSGQpSSFRpTNLNNPpSGTSGWR856 derived from WT Ire1. (C) Fragmentation 900 
spectrum 1462 for the peptide 834KLDpSGQp(SS)FRpTNLNNPp(SGTS)GWR856 derived 901 
from L745A-Ire1. Detected mass to charge ratios for the +1y (red) and +1b (oranges) ion series 902 
are shown. In addition, one phosphoryl group is bound to S840 or S841, another phosphoryl 903 
group to S850, T852, or S853. 904 
Figure 3. Mutation of phosphorylation sites in the activation loop decreases, but does 905 
not abolish, cleavage of HAC1 mRNA by Ire1. (A) Northern blots for HAC1, KAR2, PDI1, 906 
and the loading control pC4/2 (40) on RNA extracted from ire1∆ strains expressing the 907 
indicated IRE1 alleles from YCplac33 or carrying empty vector (‘-‘). Mid-exponential growth 908 
phase cells were treated with 2 mM DTT for the indicated times. Abbreviations: HAC1u - 909 
unspliced HAC1 mRNA, HAC1i - spliced HAC1 mRNA, 1st + i. - 1st exon of HAC1u mRNA 910 
plus the intron, and 1st - 1st exon of HAC1u mRNA. (B) Quantification and 95% (open 911 
symbols), 99% (half-filled symbols), or 99.9% (filled symbols) confidence intervals of the 912 
percentage of HAC1i mRNA (% HAC1i), (C) the percentage of HAC1 mRNA cleavage (% 913 
Cleavage), (D) induction of KAR2 and of (E) PDI1 mRNAs. Bars represent the standard error 914 
(n = 8 for the WT, n = 5 for all other strains). The confidence intervals for % HAC1i, % 915 
cleavage, ln-transformed KAR2 and PDI1 mRNA levels were calculated using an ordinary 916 
two-way ANOVA with Tukey’s correction for multiple comparisons (69). Abbreviations: 2S-917 
A = S840-A S841A, P-A = S837A S840A S841A T844A S850A and Q-A = S840A S841A 918 
T844A S850A. 919 
Figure 4. Mutation of all phosphorylation sites in the activation loop decreases, but does 920 
not abolish, induction of UPRE-lacZ reporters. (A) β-Galactosidase activity standardised 921 
to total cellular protein before, 1 h, and 2 h after induction of ER stress with 2 mM DTT in 922 
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mid-exponential ire1∆ cells expressing the indicated IRE1 alleles from YCplac33 or carrying 923 
empty vector (‘-‘). Bars represent standard errors (n = 3 for all strains). (B) 95% (open 924 
symbols), 99% (half-filled symbols), or 99.9% (filled symbols) confidence intervals (CI) 925 
were calculated for the ln-transformed data with an ordinary two-way ANOVA with Tukey’s 926 
correction for multiple comparisons. 927 
Figure 5. Activation loop phosphorylation is dispensable for clustering of Ire1 in vivo. 928 
Location of Sec63-GFP and Ire1-mCherry in unstressed cells and cells exposed to 2 mM 929 
DTT for 15 min, 1 h or after wash out of DTT for 1 h from cells treated with 2 mM DTT for 930 
2 h. Sec63-GFP was expressed from the single copy URA3 plasmid pJK59 in ire1∆ cells 931 
transformed with single copy LEU2 plasmids derived from pEvA97 that carry the indicated 932 
IRE1 alleles. Images covering ~100 cells were taken, except for the DTT wash out 933 
experiment in which ~20 cells were analysed. Representative images are shown. Scale bar – 5 934 
µm. 935 
Figure 6. Survival of ER stress by activation loop mutants. Survival of ER stress induced 936 
with 0.4 and 0.8 µg/ml tunicamycin (Tm). Serial 10-fold dilutions of fresh overnight cultures 937 
of ire1∆ cells expressing the indicated IRE1 alleles from YCplac33 or carrying empty vector 938 
(‘-‘) were spotted on SD minus uracil plates containing 0.4 or 0.8 µg/ml Tm and allowed to 939 
grow for 2-3 d before taking photographs. #1 and #2 indicate two independent transformants 940 
for the S840A S841A and Q-A mutants. The experiment was repeated three times with 941 
qualitatively similar results. 942 
Figure 7. Expression of WT and mutant Ire1 proteins. (A) Western blots for HA-tagged 943 
Ire1 and Act1 isolated from mid-exponential growth phase ire1∆ strains expressing the 944 
indicated IRE1 alleles from YCplac33 or carrying empty vector (‘-‘). Cells were treated for 2 945 
h with 2 mM DTT where indicated (‘+’). PVDF membranes were stained with Ponceau S 946 
after electrotransfer of proteins from 8% SDS-PAGE gels. (B) Quantification of Ire1-HA 947 
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levels relative to the Act1 loading control. The expression level of Ire1-HA in untreated WT 948 
cells was arbitrarily set to 1.0. The data were analysed with an ordinary two-way ANOVA 949 
with Tukey’s correction for multiple comparisons. No significant differences in Ire1-HA 950 
expression levels were detected, except for the negative control strain transformed with 951 
empty vector. Bars represent standard errors (n = 7 for the WT, n = 4 for the Q-A, D836A Q-952 
A, P-A, and D836A P-A mutants, and n = 3 for the D836A, S840A S841A, and D836A 953 
S840A S841A mutants and the strain transformed with empty vector). 954 
Figure 8. D836 is required for cleavage of HAC1 mRNA by activation loop mutants. (A) 955 
Northern blots for HAC1, KAR2, PDI1, and the loading control pC4/2 (40) on RNA extracted 956 
from ire1∆ strains expressing the indicated IRE1 alleles from YCplac33 or carrying empty 957 
vector (‘-‘). Mid-exponential growth phase cells were treated with 2 mM DTT for the 958 
indicated times. (B) Quantification of the percentage of HAC1i mRNA (% HAC1i), (C) the 959 
percentage of HAC1 mRNA cleavage (% Cleavage), (D) induction of KAR2 and of (E) PDI1 960 
mRNAs. Bars represent standard errors. * - P ≤ 0.05, ** - P ≤ 0.01, *** - P ≤ 0.001, and 961 
**** - P ≤ 0.0001. P values for % HAC1i and % cleavage were determined by Welch’s test 962 
followed by a Games-Howell post-hoc test. (n = 12 for the WT, n = 4 for the empty vector 963 
transformed ire1∆ strain, and n = 6 for all other strains). P values for KAR2 and PDI1 964 
induction were obtained from an ordinary two-way ANOVA with Tukey’s correction for 965 
multiple comparisons on the ln-transformed data. 966 
Figure 9. D836 is required for induction of UPRE-lacZ reporters by activation loop 967 
mutants. β-Galactosidase activity standardised to total cellular protein before, 1 h, and 2 h 968 
after induction of ER stress with 2 mM DTT in mid-exponential ire1∆ cells expressing the 969 
indicated IRE1 alleles from YCplac33 or carrying empty vector (‘-‘). Bars represent standard 970 
errors (n = 12 for WT Ire1 and cells transformed with empty vector, n = 9 for all other 971 
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strains). * - P ≤ 0.05 and **** - P ≤ 0.0001. P values were obtained from an ordinary two-972 
way ANOVA with Tukey’s correction for multiple comparisons on the ln-transformed data. 973 
Figure 10. D836 is not required for clustering of Ire1 in vivo. Location of Sec63-GFP and 974 
Ire1-mCherry in unstressed cells and cells exposed to 2 mM DTT for 15 min, 1 h or after 975 
wash out of DTT for 1 h from cells treated with 2 mM DTT for 2 h. Sec63-GFP was 976 
expressed from plasmid pJK59 in ire1∆ cells transformed with single copy LEU2 plasmids 977 
derived from pEvA97 that carry the indicated IRE1 alleles. Images covering ~100 cells were 978 
taken, except for the DTT wash out experiment in which ~20 cells were analysed. 979 
Representative images are shown. Scale bar – 5 µm. 980 
Figure 11. Survival of ER stress by activation loop mutants requires D836. Survival of 981 
ER stress induced with 0.8 µg/ml Tm or 1.5 mM DTT. Serial 10-fold dilutions of fresh 982 
overnight cultures of ire1∆ cells expressing the indicated IRE1 alleles from YCplac33 or 983 
carrying empty vector were spotted on SD minus uracil plates containing 0.8 µg/ml Tm or 1.5 984 
mM DTT and allowed to grow for 2-3 d before taking photographs. The experiment was 985 
repeated three times with qualitatively similar results. 986 
Figure 12. Mutation of phosphorylation sites in the activation does not alter inactivation 987 
of Ire1. (A) Northern blots for HAC1, KAR2, PDI1, and the loading control pC4/2 (40) on 988 
RNA extracted from ire1∆ strains expressing the indicated IRE1 alleles from YCplac33 or 989 
carrying empty vector (‘-‘). Mid-exponential growth phase cells were treated with 2 mM 990 
DTT for 2 h, before washing the cells once with culture medium and resuspending the cells in 991 
fresh, DTT-free medium. (B) Plot of the natural logarithm of the percentage of HAC1i mRNA 992 
over time. (C) Plot of the natural logarithm of the percentage of HAC1 mRNA splicing over 993 
time. (D) Plot of the natural logarithm of KAR2 mRNA over time. (E) Plot of the natural 994 
logarithm of PDI1 mRNA over time. Dotted lines represent the 95% confidence intervals of 995 
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the linear regression models. The first order rate constants, koff, were calculated from the 996 
slopes of the linear regression models. 997 
Figure 13. Mutation of all phosphorylation sites in the activation loop of Ire1 is epistatic 998 
to overexpression of Ptc2. (A) Effect of overexpression of WT and catalytically inactive 999 
E37A-D38A Ptc2 from the GAL1 promoter on a 2 µ plasmid on survival of ER stress induced 1000 
with 0.8 µg/ml Tm. Fresh overnight cultures of ire1∆ cells expressing the indicated IRE1 1001 
alleles from YCplac33 and the indicated PGAL1-PTC2 alleles from pRSII422 were grown on 1002 
1% (w/v) raffinose and 2% (w/v) galactose and spotted in 10 fold serial dilutions onto plates 1003 
containing 1% (w/v) raffinose and 2% (w/v) galactose and, where indicated, 0.8 µg/ml Tm. 1004 
Plates were incubated for 7 d at 30 °C. The negative decadic logarithms of the dilutions D of 1005 
the 10-fold dilution series are shown on top of the plates. The threshold dilutions for 1006 
untreated cells, DT,u, and cells exposed to tunicamycin, DT,Tm, and the difference between 1007 
both threshold dilutions, ∆logDT, are shown to the right of the plates. (B) Effect of 1008 
overexpression of Dcr2 by placing the GAL1 promoter in front of the endogenous DCR2 gene 1009 
on survival of ER stress. Serial 10-fold dilutions of fresh overnight cultures of ire1∆ cells and 1010 
ire1∆ PGAL1-T7-DCR2 cells expressing WT IRE1 from YCplac33 grown on 1% (w/v) 1011 
raffinose and 2% (w/v) galactose were spotted onto plates containing 1% (w/v) raffinose and 1012 
2% (w/v) galactose and, where indicated, 0.4 µg/ml or 0.8 µg/ml Tm. Plates were incubated 1013 
for 4 d at 30 °C. (C) Effect of overexpression of WT and catalytically inactive H338A Dcr2 1014 
from the GAL1 promoter on a 2 µ plasmid on survival of ER stress. Fresh overnight cultures 1015 
of ire1∆ cells expressing the indicated IRE1 alleles from YCplac33 and the indicated PGAL1-1016 
DCR2 alleles from pRSII422 were grown on 1% (w/v) raffinose and 2% (w/v) galactose and 1017 
spotted in 10 fold serial dilutions onto plates containing 1% (w/v) raffinose and 2% (w/v) 1018 
galactose and, where indicated, 0.4 µg/ml Tm. Plates were incubated for 7 d at 30 °C. (D) 1019 
Deletion of both DCR2 and PTC2 does not affect survival of ER. Serial 10-fold dilutions of 1020 
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fresh overnight cultures of ire1∆ cells, ire1∆ dcr2∆ cells, ire1∆ ptc2∆ cells, and ire1∆ dcr2∆ 1021 
ptc2∆ cells expressing the indicated IRE1 alleles from YCplac33 were spotted onto SD minus 1022 
uracil plates containing 0.4 µg/ml Tm, 1 mM DTT, or 2 mM 2-deoxy-D-glucose (2-DOG) to 1023 
induce ER stress. Plates were incubated for 3 d at 30 °C. All spotting assays were repeated at 1024 
least once with qualitatively similar results. 1025 
  1026 
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Table 1. Oligodeoxynucleotides. Restriction sites are underlined. Mutagenic base 1027 
substitutions in oligodeoxynucleotides used for site-directed mutagenesis are shown in bold. 1028 
Name Sequence 
8691G TGTGCAGGATCCCAAAGATTCAAAATTTTGCCGCC 
DCR2-H338A-F CAATGGTATGGGGAAATGCCGACGACGAGGGAAGCT 
DCR2-H338A-R AGCTTCCCTCGTCGTCGGCATTTCCCCATACCATTG 
H4075A04 TGCCTTAGAACTTTCATAGC 
H8293 GGTCTTTGCAAAAAACTAGACGCCGGCCAGGCAGCATTTAGAGCAA
AT 
H8294 ATTTGCTCTAAATGCTGCCTGGCCGGCGTCTAGTTTTTTGCAAAGA
CC 
H8623 TTGATATCAGACTTTGGTCTTTGCAAAAAACTAGCTAGCGGTCAGT
CTTCATTTAGAACAAATTTGAATAACC 
H8624 GGTTATTCAAATTTGTTCTAAATGAAGACTGACCGCTAGCTAGTTT
TTTGCAAAGACCAAAGTCTGATATCAA 
H8625 TTTGATATCAGACTTTGGTCTTTGCAAAAAACTAGCTAGCGGTCAG
GCTGCATTTAGAACAAATTTG 
H8626 CAAATTTGTTCTAAATGCAGCCTGACCGCTAGCTAGTTTTTTGCAA
AGACCAAAGTCTGATATCAAA 
H8627 ATCAGACTTTGGTCTTTGCAAAAAACTAGCTAGCGGTCAGGCAGCA
TTTAGAGCAAATTTGAATAACCCTGCA 
H8628 GGGTTATTCAAATTTGCTCTAAATGCTGCCTGACCGCTAGCTAGTT
TTTTGCAAAGACCAAAGTCTGAT 
H8629 ATCAGACTTTGGTCTTTGCAAAAAGCTAGCCGCCGGCCAGGCAGCA
TTTAGAGCAAATTTGAATAACCCTGCA 
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H8630 GGGTTATTCAAATTTGCTCTAAATGCTGCCTGGCCGGCGGCTAGCT
TTTTGCAAAGACCAAAGTCTGAT 
H9327 TCATAAATACGGATACGTCTTTCTGTACCTCCATAGCCAGCATAAC
CACCAAGCTTCGTACGCTGCAGG 
H9328 AGTTTTATACTTAAGTATCGAAGACCAGCACCGTGGTTAAAAATCT
TAACAGGCCACTAGTGGATCTG 
H9329 GCCGGAGGTCTTGCTCTTGGATTGGCTGGAAGGGTCAAGATTTTCT
GCATAAGCTTCGTACGCTGCAGG 
H9330 TCCCTAGGATTTTGACTATTCCATTGTTGTATAAAATATAGAGAAC
CAGAAGGCCACTAGTGGATCTG 
H9331 ACTACCAAGTATAATAGGTACCTTTGATACAGCCTCGGTAACCGGA
TCATACCCATTTGCTGTCCACCAG 
H9332 CCGGAGTGGCTCTCTTTATCAATTACCGGGTTTGATAGAATTTGTC
CCATACCCATTTGCTGTCCACCAG 
PTC2-E37A-D38A-F ACATTAGGCTCTAGAATGTGTGAAGCCGCCATGGACATCCGCCACC 
PTC2-E37A-D38A-R GGTGGCGGATGTCCATGGCGGCTTCACACATTCTAGAGCCTAATGT 
U5803H01 TAAATGGCTAGCATGACTGGTGGACAGCAAATGGGTG 
U5803H02 GATCCACCCATTTGCTGTCCACCAGTCATGCTAGCCATTTAAT 
  1029 
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Table 2. Saccharomyces cerevisiae strains. All strains, except Y01907, carry the alleles 1030 
MATa ade2-1 can1-100 his3-11,-15 leu2-3,-112 trp1-1 ura3-1. 1031 
Name Genotype Reference 
W303-1A  (33) 
PWY 260  ire1∆∷TRP1 his3-11,15∷HIS3+UPRE-lacZ leu2-3,-
112∷LEU2+UPRE-lacZ 
(23) 
MSY 14-02 ire1∆∷kanMX2 This study. 
MSY 792-02 ire1∆∷TRP1 dcr2∆::kanMX2 his3-11,15∷HIS3+UPRE-
lacZ leu2-3,-112∷LEU2+UPRE-lacZ 
This study. 
MSY 793-06 ire1∆∷TRP1 ptc2∆::kanMX2 his3-11,15∷HIS3+UPRE-
lacZ leu2-3,-112∷LEU2+UPRE-lacZ 
This study. 
MSY 794-11 ire1∆∷TRP1 kanMX6-PGAL1,10-T7-DCR2 his3-
11,15∷HIS3+UPRE-lacZ leu2-3,-112∷LEU2+UPRE-lacZ 
This study. 
MSY 795-01 ire1∆∷TRP1 kanMX6-PGAL1,10-T7-PTC2 his3-
11,15∷HIS3+UPRE-lacZ leu2-3,-112∷LEU2+UPRE-lacZ 
This study. 
MSY 796-02 ire1∆∷TRP1 dcr2∆::kanMX2 ptc2∆::hphNT1 his3-
11,15∷HIS3+UPRE-lacZ leu2-3,-112∷LEU2+UPRE-lacZ 
This study. 
MSY 797-02 ire1∆∷TRP1 dcr2∆::hphNT1 ptc2∆::kanMX2 his3-
11,15∷HIS3+UPRE-lacZ leu2-3,-112∷LEU2+UPRE-lacZ  
This study. 
   
Y01907 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ire1∆∷kanMX4 (70) 
 1032 
 1033 
Mg2+ 
S. cerevisiae    828 DFGLCKK LD-SG-QSSF-RT-NLNN PS-GTSGWRAPE 859 
S. bayanus       828 DFGLCKK LD-SG-QSSF-RT-NLNN PS-GTSGWRAPE 859 
A. fumigatus     858 DFGLCKK LD-D-NQSSFRAT--TAH AA-GTSGWRAPE 889 
A. gossypii      843 DFGLCKK LEAE--ESSF-KT-NINN AA-GTSGWRAPE 874 
C. albicans      928 DFGLCKK LEND--QSSFRAT--TQN AASGTSGWRAPE 960 
T. reesei        953 DFGLCKK LE-D-RQSSFGAT--TGR AA-GTSGWRAPE 984 
C. elegans       659 DFGLCKR VQP-GKNS-ISRGIASG- LA-GTDGWIAPE 691 
D. melanogaster  690 DFGLCKK LNF-GKTS-FSRR--SG- VT-GTDGWIAPE 720 
H. sapiens alpha 711 DFGLCKK LAV-GRHS-FSRR--SG- VP-GTEGWIAPE 741 
H. sapiens beta  660 DFGLCKK LPA-GRCS-FSLH--SG- IP-GTEGWMAPE 690 
A. thaliana 1    628 DMGISKR LPAD---TSA-KTRNST- GLGGSSGWQAPE 660 
A. thaliana 2    590 DMGISKR MSRD--MSSLGH--LAT- GS-GSSGWQAPE 620 
Activation loop 
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